BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19129457)

  • 1. Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes.
    Duenas-Decamp MJ; Peters PJ; Burton D; Clapham PR
    J Virol; 2009 Mar; 83(6):2575-83. PubMed ID: 19129457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues.
    Peters PJ; Dueñas-Decamp MJ; Sullivan WM; Clapham PR
    J Neuroimmune Pharmacol; 2007 Mar; 2(1):32-41. PubMed ID: 18040824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
    Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
    Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
    O'Connell O; Repik A; Reeves JD; Gonzalez-Perez MP; Quitadamo B; Anton ED; Duenas-Decamp M; Peters P; Lin R; Zolla-Pazner S; Corti D; Wallace A; Wang S; Kong XP; Lu S; Clapham PR
    J Virol; 2013 Jan; 87(1):187-98. PubMed ID: 23055568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.
    Peters PJ; Duenas-Decamp MJ; Sullivan WM; Brown R; Ankghuambom C; Luzuriaga K; Robinson J; Burton DR; Bell J; Simmonds P; Ball J; Clapham PR
    Retrovirology; 2008 Jan; 5():5. PubMed ID: 18205925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
    Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
    Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.
    Peters PJ; Bhattacharya J; Hibbitts S; Dittmar MT; Simmons G; Bell J; Simmonds P; Clapham PR
    J Virol; 2004 Jul; 78(13):6915-26. PubMed ID: 15194768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of HIV-1 macrophage-tropism among R5 envelopes occurs before detection of neutralizing antibodies.
    Richards KH; Aasa-Chapman MM; McKnight A; Clapham PR
    Retrovirology; 2010 May; 7():48. PubMed ID: 20507591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.
    Peters PJ; Sullivan WM; Duenas-Decamp MJ; Bhattacharya J; Ankghuambom C; Brown R; Luzuriaga K; Bell J; Simmonds P; Ball J; Clapham PR
    J Virol; 2006 Jul; 80(13):6324-32. PubMed ID: 16775320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic Correlates of HIV-1 Macrophage Tropism.
    Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
    J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the 375W mutation for HIV-1 tropism and vaccine development.
    Verdejo-Torres O; Vargas-Pavia T; Fatima S; Clapham PR; Duenas-Decamp MJ
    J Virol; 2024 Jan; 98(1):e0152223. PubMed ID: 38169306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.
    Joseph SB; Arrildt KT; Swanstrom AE; Schnell G; Lee B; Hoxie JA; Swanstrom R
    J Virol; 2014 Feb; 88(4):1858-69. PubMed ID: 24307580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection.
    Musich T; Peters PJ; Duenas-Decamp MJ; Gonzalez-Perez MP; Robinson J; Zolla-Pazner S; Ball JK; Luzuriaga K; Clapham PR
    J Virol; 2011 Mar; 85(5):2397-405. PubMed ID: 21159865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue.
    Gonzalez-Perez MP; O'Connell O; Lin R; Sullivan WM; Bell J; Simmonds P; Clapham PR
    Retrovirology; 2012 Mar; 9():20. PubMed ID: 22420378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral determinants of HIV-1 macrophage tropism.
    Duncan CJ; Sattentau QJ
    Viruses; 2011 Nov; 3(11):2255-79. PubMed ID: 22163344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.
    Sterjovski J; Roche M; Churchill MJ; Ellett A; Farrugia W; Gray LR; Cowley D; Poumbourios P; Lee B; Wesselingh SL; Cunningham AL; Ramsland PA; Gorry PR
    Virology; 2010 Sep; 404(2):269-78. PubMed ID: 20570309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stoichiometry for entry and binding properties of the Env protein of R5 T cell-tropic HIV-1 and its evolutionary variant of macrophage-tropic HIV-1.
    Bonner X; Sondgeroth A; McCue A; Nicely N; Tripathy A; Spielvogel E; Moeser M; Ke R; Leiderman K; Joseph SB; Swanstrom R
    mBio; 2024 Apr; 15(4):e0032124. PubMed ID: 38426750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes.
    Peters PJ; Gonzalez-Perez MP; Musich T; Moore Simas TA; Lin R; Morse AN; Shattock RJ; Derdeyn CA; Clapham PR
    Retrovirology; 2015 Jun; 12():48. PubMed ID: 26055104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
    Kato K; Sato H; Takebe Y
    J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.